BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29483235)

  • 21. SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
    Sinha S; Chatterjee SS; Biswas M; Nag A; Banerjee D; De R; Sengupta A
    Exp Hematol; 2018 Jun; 62():39-44.e2. PubMed ID: 29596882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling.
    Valencia AM; Collings CK; Dao HT; St Pierre R; Cheng YC; Huang J; Sun ZY; Seo HS; Mashtalir N; Comstock DE; Bolonduro O; Vangos NE; Yeoh ZC; Dornon MK; Hermawan C; Barrett L; Dhe-Paganon S; Woolf CJ; Muir TW; Kadoch C
    Cell; 2019 Nov; 179(6):1342-1356.e23. PubMed ID: 31759698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly and interaction of core subunits of BAF complexes and crystal study of the SMARCC1/SMARCE1 binary complex.
    Dong C; Zhang R; Xu L; Liu B; Chu X
    Biochem Biophys Res Commun; 2022 Apr; 599():9-16. PubMed ID: 35158202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MYC by the SMARCB1 tumor suppressor.
    Weissmiller AM; Wang J; Lorey SL; Howard GC; Martinez E; Liu Q; Tansey WP
    Nat Commun; 2019 May; 10(1):2014. PubMed ID: 31043611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Pluripotent Stem Cell Fate Regulation by SMARCB1.
    Carmel-Gross I; Levy E; Armon L; Yaron O; Waldman Ben-Asher H; Urbach A
    Stem Cell Reports; 2020 Nov; 15(5):1037-1046. PubMed ID: 33125876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia.
    Chambers C; Cermakova K; Chan YS; Kurtz K; Wohlan K; Lewis AH; Wang C; Pham A; Dejmek M; Sala M; Loeza Cabrera M; Aguilar R; Nencka R; Lacorazza HD; Rau RE; Hodges HC
    Cancer Res; 2023 Apr; 83(7):983-996. PubMed ID: 36662812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions.
    Grossi E; Raimondi I; Goñi E; González J; Marchese FP; Chapaprieta V; Martín-Subero JI; Guo S; Huarte M
    Nat Commun; 2020 Feb; 11(1):936. PubMed ID: 32071317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SWI/SNF Complex Protein Snr1 Is a Tumor Suppressor in
    Xie G; Chen H; Jia D; Shu Z; Palmer WH; Huang YC; Zeng X; Hou SX; Jiao R; Deng WM
    Cancer Res; 2017 Feb; 77(4):862-873. PubMed ID: 27923836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1.
    Dubey R; Lebensohn AM; Bahrami-Nejad Z; Marceau C; Champion M; Gevaert O; Sikic BI; Carette JE; Rohatgi R
    Cancer Res; 2016 Oct; 76(19):5810-5821. PubMed ID: 27503929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
    McKenna ES; Sansam CG; Cho YJ; Greulich H; Evans JA; Thom CS; Moreau LA; Biegel JA; Pomeroy SL; Roberts CW
    Mol Cell Biol; 2008 Oct; 28(20):6223-33. PubMed ID: 18710953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.
    Nakayama RT; Pulice JL; Valencia AM; McBride MJ; McKenzie ZM; Gillespie MA; Ku WL; Teng M; Cui K; Williams RT; Cassel SH; Qing H; Widmer CJ; Demetri GD; Irizarry RA; Zhao K; Ranish JA; Kadoch C
    Nat Genet; 2017 Nov; 49(11):1613-1623. PubMed ID: 28945250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SWI/SNF subunit/tumor suppressor BAF47/INI1 is essential in cell cycle arrest upon skeletal muscle terminal differentiation.
    Joliot V; Ait-Mohamed O; Battisti V; Pontis J; Philipot O; Robin P; Ito H; Ait-Si-Ali S
    PLoS One; 2014; 9(10):e108858. PubMed ID: 25271443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
    Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.
    Drosos Y; Myers JA; Xu B; Mathias KM; Beane EC; Radko-Juettner S; Mobley RJ; Larsen ME; Piccioni F; Ma X; Low J; Hansen BS; Peters ST; Bhanu NV; Dhanda SK; Chen T; Upadhyaya SA; Pruett-Miller SM; Root DE; Garcia BA; Partridge JF; Roberts CWM
    Mol Cell; 2022 Jul; 82(13):2472-2489.e8. PubMed ID: 35537449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SRG3/mBAF155 stabilizes the SWI/SNF-like BAF complex by blocking CHFR mediated ubiquitination and degradation of its major components.
    Jung I; Sohn DH; Choi J; Kim JM; Jeon S; Seol JH; Seong RH
    Biochem Biophys Res Commun; 2012 Feb; 418(3):512-7. PubMed ID: 22285184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation.
    Sansam CG; Roberts CW
    Cell Cycle; 2006 Mar; 5(6):621-4. PubMed ID: 16582616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SWI/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond.
    Lu P; Roberts CW
    Nucleus; 2013; 4(5):374-8. PubMed ID: 24145903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.